• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Bolton Jeffrey was granted 4,670 shares, increasing direct ownership by 5% to 107,622 units (SEC Form 4)

    4/11/25 8:49:57 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Bolton Jeffrey

    (Last) (First) (Middle)
    6688 N. CENTRAL EXPRESSWAY
    SUITE 1300

    (Street)
    DALLAS TX 75206

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Enhabit, Inc. [ EHAB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/10/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/10/2025 A 4,670(1) A $8.03 107,622 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents deferred stock units acquired in lieu of a cash retainer fee at the election of the Reporting Person pursuant to the Enhabit, Inc. Deferred Director Compensation Plan.
    Remarks:
    /s/ Sarah W. Braley, Attorney in Fact 04/10/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $EHAB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    3/7/2024$9.50Sell → Neutral
    UBS
    12/12/2023$12.00Market Perform
    TD Cowen
    6/20/2023$10.00Underperform
    SVB Securities
    3/16/2023$15.00Neutral
    Goldman
    12/13/2022$18.00Market Perform
    CJS Securities
    More analyst ratings

    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bolton Jeffrey was granted 4,670 shares, increasing direct ownership by 5% to 107,622 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      4/11/25 8:49:57 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Director Hoeflinger Erin was granted 2,958 shares, increasing direct ownership by 6% to 54,316 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      4/11/25 8:48:40 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Director Rush Gregory S was granted 3,113 shares, increasing direct ownership by 6% to 53,706 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      4/11/25 8:47:21 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enhabit Announces Participation in Goldman Sachs 46th Annual Global Healthcare Conference

      Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. Enhabit's President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, June 10, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their familie

      5/20/25 4:10:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Reports First Quarter 2025 Financial Results

      Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. "Enhabit's first quarter 2025 results are a product of steadfast execution of our strategies," said Barb Jacobsmeyer, president and CEO of Enhabit. "Home health census grew 3.7% sequentially and hospice census grew 12.3% year over year. The combination of strong growth, improved profitability and continued balance sheet improvements resulted in a leverage ratio now below 4.5 times. This enables us to formally exit the covenant relief period restrictions in our

      5/7/25 4:15:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

      Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/885393432 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Hea

      4/17/25 4:12:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    SEC Filings

    See more
    • Enhabit Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Enhabit, Inc. (0001803737) (Filer)

      6/9/25 4:21:29 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Enhabit Inc.

      10-Q - Enhabit, Inc. (0001803737) (Filer)

      5/8/25 4:23:08 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Enhabit, Inc. (0001803737) (Filer)

      5/7/25 5:10:42 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      12/12/24 5:01:19 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      12/11/24 5:56:33 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Director Bolton Jeffrey bought $77,177 worth of shares (10,000 units at $7.72), increasing direct ownership by 12% to 94,144 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      11/12/24 5:14:12 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care